semaglutide columbus ohio Columbus, Diabetes Drug Could Help Reduce

2.4

GLP-1 drug shows little benefit for people with Parkinsons disease 5 February 2025 The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinsons disease, finds a new study led by UCL researchers

Based on these studies, future studies (both preclinical and clinical) should also assess mood as a construct of reward pathway associated with GLP-1

Its really important with these types of drugs that pharmacists and providers make sure to provide their patients with adequate counseling, education, and materials and be available when patients have questions, says Tenille Davis, a pharmacist and chief advocacy officer of the Alliance for Pharmacy Compounding, which represents the interests of compounding pharmacies in the U.S